Talphera (TLPH)

• Market cap: $38.8M
• 1 day: 2.99%
• 5 days: 5.43%
• 1 month: 7.25%
• 3 months: -22.16%
• 6 months: -10.42%
• Year to date: -28.2%
• 1 year: 35.21%
• 5 years: -97.66%
• 10 years: -98.72%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Employees: 13